![logo](/logos/NNVC.webp)
NanoViricides, Inc.
AMEX:NNVC
1.02 (USD) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | NanoViricides, Inc. |
Symbool | NNVC |
Munteenheid | USD |
Prijs | 1.1 |
Beurswaarde | 12,832,600 |
Dividendpercentage | 0% |
52-weken bereik | 1 - 2 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Anil R. Diwan Ph.D. |
Website | https://www.nanoviricides.com |
An error occurred while fetching data.
Over NanoViricides, Inc.
NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)